Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Demir Firat, A. Ciledag, P. Akin Kabalak, D. Karnak, S. Erekul, O. Kayacan (Ankara, Turkey). Pulmonary alveolar proteinosis therapy success with combined lavage procedures: a case report. Eur Respir J 2009; 34: Suppl. 53, 734

Member's Comments

No comment yet.

Related content which might interest you: Idiopathic pulmonary alveolar proteinosis: GM CSF therapy and whole lung lavage a case report Source: Eur Respir J 2003; 22: Suppl. 45, 44s Year: 2003 Pulmonary alveolar proteinosis: report of two cases Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Outpatient lobar lavage: a novel approach to managing pulmonary alveolar proteinosis Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 Pulmonary alveolar proteinosis: failure of treatment by bronchoscopic lobar lavages and GM-CSF treatment in a child Source: Eur Respir J 2003; 22: Suppl. 45, 309s Year: 2003 Pulmonary alveolar proteinosis: from classification to therapy Source: Breathe, 16 (2) 200018; 10.1183/20734735.0018-2020 Year: 2020 Alveolar proteinosis: bronchopulmonary lavage - procedure and complications Source: Eur Respir J 2002; 20: Suppl. 38, 616s Year: 2002 Pulmonary alveolar proteinosis (PAP) - clinical features and response to treatment by bronchofiberoscopic lobar lavage Source: Eur Respir J 2005; 26: Suppl. 49, 541s Year: 2005 Pulmonary alveolar proteinosis and long-term outcome after bronchopulmonary lavage Source: International Congress 2017 – Paediatric bronchology Year: 2017 Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 526-531 Year: 2004 BAL cytology in pulmonary alveolar proteinosis: a review of 7 cases Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease Year: 2008 Wash-out kinetics and efficacy of a modified lavage technique for alveolar proteinosis Source: Eur Respir J 2012; 40: 1468-1474 Year: 2012 Pulmonary alveolar proteinosis and GMSCF antibodies: a case series Source: Eur Respir J 2004; 24: Suppl. 48, 670s Year: 2004 Whole lung lavage with intermittent double lung ventilation: a new technique for managing pulmonary alveolar proteinosis Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004 Call for an international survey on therapeutic lavage for pulmonary alveolar proteinosis Source: Eur Respir J 2012; 39: 1049 Year: 2012 The benefits of whole lung lavage in pulmonary alveolar proteinosis Source: Eur Respir J 2004; 23: 503-505 Year: 2004 Pulmonary alveolar proteinosis, study of 29 cases Source: Annual Congress 2010 - Rare diffuse lung diseases Year: 2010 Novel method of whole lung lavage therapy using biphasic cuirass ventilator for pulmonary alveolar proteinosis; the retrospective observational study. Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009 Mini-whole lung lavage to treat pulmonary alveolar proteinosis (PAP) Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Long term follow up of the whole lung lavage programme in patients with pulmonary alveolar proteinosis: an update Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006